newsfilter
← Latest News
Business Wire·

Sangamo Therapeutics Announces Third Quarter 2024 Conference Call and Webcast

Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, announced today that the company has scheduled the release of its third quarter 2024 financial results after the market close on Tuesday, November